Correction: FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma

Correction: FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma

Bibliographic Details
Main Authors:	Liang Wang, Caiyan Shi, Jie Yu, Yilin Xu
Format:	Article
Language:	English
Published:	BMC 2022-12-01
Series:	Cancer Cell International
Online Access:	https://doi.org/10.1186/s12935-022-02802-9

Similar Items

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
by: Kitti Intuyod, et al.
Published: (2021-05-01)

CircFOXM1 acts as a ceRNA to upregulate SMAD2 and promote the progression of nasopharyngeal carcinoma
by: Shuai Pei, et al.
Published: (2022-05-01)

FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression
by: Guohui Hu, et al.
Published: (2019-05-01)

Correction to: Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma
by: Xue Zhang, et al.
Published: (2021-06-01)

circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1
by: Zhuoan Cheng, et al.
Published: (2019-07-01)

USP21 Promotes the Progression of Nasopharyngeal Carcinoma by Regulating FOXM1
by: Xiaofeng Li, et al.
Published: (2023-01-01)

RNA-binding protein HNRNPD promotes chondrocyte senescence and osteoarthritis progression through upregulating FOXM1
by: Huanyu Jiang, et al.
Published: (2024-12-01)

CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
by: Jun Zhang, et al.
Published: (2021-11-01)

Retracted: USP21 Promotes the Progression of Nasopharyngeal Carcinoma by Regulating FOXM1
by: Stem Cells International
Published: (2024-01-01)

Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma
by: Xue Zhang, et al.
Published: (2017-08-01)

The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis
by: Yongjia Wang, et al.
Published: (2022-10-01)

Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes
by: Philpott Michael P, et al.
Published: (2010-02-01)

Retraction Note: Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
by: Lisha Zhou, et al.
Published: (2024-09-01)

RETRACTED ARTICLE: Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
by: Lisha Zhou, et al.
Published: (2023-07-01)

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
by: Shuai Li, et al.
Published: (2021-11-01)

DDX56 promotes EMT and cancer stemness via MELK-FOXM1 axis in hepatocellular carcinoma
by: Qing Li, et al.
Published: (2024-06-01)

METTL3/YTHDC1-mediated upregulation of LINC00294 promotes hepatocellular carcinoma progression
by: Rulin Zhang, et al.
Published: (2023-12-01)

Role of MTDH, FOXM1 and microRNAs in Drug Resistance in Hepatocellular Carcinoma
by: Xiangbing Meng, et al.
Published: (2014-07-01)

Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
by: Chunyan Gu, et al.
Published: (2018-11-01)

FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
by: Zhu X, et al.
Published: (2020-10-01)

FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma
by: Yingru Zhi, et al.
Published: (2019-06-01)

Succinylation modification-mediated upregulation of Sp1 promotes hepatocellular carcinoma cell proliferation
by: Yehong Han, et al.
Published: (2024-11-01)

Correction: ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and KIF4A
by: Meng Cui, et al.
Published: (2023-08-01)

Dysregulation of miR-23b-5p promotes cell proliferation via targeting FOXM1 in hepatocellular carcinoma
by: Xinchen Yang, et al.
Published: (2021-03-01)

FoxM1 promotes glioma cells progression by up-regulating Anxa1 expression.
by: Shi-Xiang Cheng, et al.
Published: (2013-01-01)

circFOXM1 promotes proliferation of non-small cell lung carcinoma cells by acting as a ceRNA to upregulate FAM83D
by: Chengtao Yu, et al.
Published: (2020-03-01)

OTUB1-mediated deubiquitination of FOXM1 up-regulates ECT-2 to promote tumor progression in renal cell carcinoma
by: Kai Zhou, et al.
Published: (2020-03-01)

Correction: SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters
by: Heyun Zhang, et al.
Published: (2021-08-01)

KDM6A promotes hepatocellular carcinoma progression and dictates lenvatinib efficacy by upregulating FGFR4 expression
by: Wenyun Guo, et al.
Published: (2023-10-01)

From imaging to clinical outcome: dual-region CT radiomics predicting FOXM1 expression and prognosis in hepatocellular carcinoma
by: Xianyu Chen, et al.
Published: (2023-09-01)

Author Correction: Caveolin-1 promotes invasion and metastasis by upregulating Pofut1 expression in mouse hepatocellular carcinoma
by: Cheng Zhang, et al.
Published: (2019-07-01)

LncRNA GACAT3 promotes esophageal squamous cell carcinoma progression through regulation of miR-149/FOXM1
by: Min Su, et al.
Published: (2021-09-01)

Interaction of STIL with FOXM1 regulates SF3A3 transcription in the hepatocellular carcinoma development
by: Haijun Zhang, et al.
Published: (2025-01-01)

Investigation of Functional Synergism of CENPF and FOXM1 Identifies POLD1 as Downstream Target in Hepatocellular Carcinoma
by: Daniel Wai-Hung Ho, et al.
Published: (2022-07-01)

Phase separation of RNF214 promotes the progression of hepatocellular carcinoma
by: Zheng-Jie He, et al.
Published: (2024-07-01)

BTF3 affects hepatocellular carcinoma progression by transcriptionally upregulating PDCD2L and inactivating p53 signaling
by: Minyu Kong, et al.
Published: (2024-12-01)

Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma
by: Ziwu Xu, et al.
Published: (2023-05-01)

ADAM17 promotes the invasion of hepatocellular carcinoma via upregulation MMP21
by: Yuqi Xiang, et al.
Published: (2020-10-01)

STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro
by: Haixiao Wang1,4,#, Kuangjie Wu1,#, Yuan Sun5, Yandong Li2,3, Mingyu Wu1, Qian Qiao1, Yuanjiang Wei1, Ze-Guang Han2,3,* & Bing Cai1,*
Published: (2012-11-01)

TMB Signature-Related RCAN2 Promotes Apoptosis by Upregulating EHF/DR5 Pathway in Hepatocellular Carcinoma
by: Yu-Jie Xu, et al.
Published: (2024-07-01)